Cime Therapeutics Inc.

Biotechnology company · Denver, Colorado, United States

Cime Therapeutics Inc. is a biotechnology company headquartered in Denver, Colorado, United States. Its earliest recorded incorporation is in 2024. It has reported private securities offerings to the US SEC, most recently $2.1 million sold in a notice filed in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

Cime Therapeutics at a glance

Typebiotechnology company

HeadquartersDenver, Colorado, United States

Earliest incorporation on record2024

SEC CIK2062575

What does Cime Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $2.1 million sold (2025).

Frequently asked questions about Cime Therapeutics

Where is Cime Therapeutics headquartered?

Cime Therapeutics Inc. is headquartered in Denver, Colorado, United States.

What does Cime Therapeutics do?

Cime Therapeutics Inc. is a biotechnology company.

When was Cime Therapeutics founded?

The earliest incorporation on record for Cime Therapeutics Inc. is in 2024, according to public company registers.

Similar companies

Vitro Biopharma, Inc.Denver, Colorado, United States
RheumaGen, Inc.Denver, Colorado, United States
BioCollective, LLCDenver, Colorado, United States
BioMedInnovations LLCDenver, North Carolina, United States
Cerecin Inc.Denver, Colorado, United States
Cascade Biocatalysts, Inc.Denver, Colorado, United States
Op-T-Mune, IncDenver, Colorado, United States
Rock Immune, Inc.Denver, Colorado, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences